Effectiveness of pharmacist counseling on medication adherence and blood pressure in patients with hypertension at a private clinic in Bali, Indonesia
DOI:
https://doi.org/10.12923/cipms-2026-0026Keywords:
blood pressure, medication adherence, hypertension, pharmacist counselingAbstract
Hypertension can be influenced by several factors, including age, genetics, lifestyle, and sex. Poor medication adherence and uncontrolled blood pressure are associated with increased morbidity and mortality; therefore, pharmacist counseling may play an important role in improving treatment outcomes. This study aimed to evaluate the effectiveness of pharmacist counseling on medication adherence and blood pressure in patients with hypertension at a private clinic in Bali, Indonesia. A quasi-experimental study with a nonequivalent pretest-posttest control group design was conducted. A total of 71 respondents participated in the study, including 28 in the control group and 43 in the intervention group, using a total sampling method. Medical record data were collected retrospectively over a 6-month period (June–November 2025) and prospectively for 5 months after the intervention (January–May 2026) to assess medication adherence using the Medication Possession Ratio (MPR) and to evaluate blood pressure. The chi-square test was used to analyze medication adherence, while the Mann–Whitney, Wilcoxon, and ANCOVA tests were used to analyze blood pressure. A significant difference in medication adherence was observed after pharmacist counseling (p = 0.006). No significant differences were observed in systolic or diastolic blood pressure after pharmacist counseling, with p = 0.318 and p = 0.623, respectively. In conclusion, pharmacist counseling was effective in improving medication adherence but did not have a statistically significant effect on blood pressure.
References
1. Indonesian Association of Cardiovascular Specialists. Atherosclerosis cardiovascular disease prevention guideline [Internet]. Jakarta: Indonesian Association of Cardiovascular Specialists; 2022. Available from: https://www.inaheart.org/panduan-prevensi-penyakit-kardiovaskular-aterosklerosis/
2. Alhawari H, Albdour Z, Alshelleh S, Musleh J, Qouzah T, Qudisat T, et al. Gender differences in blood pressure control among hypertensive patients: a cross-sectional study at a tertiary hospital. J Clin Hypertens (Greenwich). 2025;27(1). doi:10.1111/jch.14975.
3. Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bress AP, Carter J, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Hypertension. 2025;82(10). doi:10.1161/HYP.0000000000000249.
4. Golna C, Poimenidou C, Giannoukari EEE, Saridi M, Liberopoulos E, Souliotis K. Assessing a pharmacist-enabled intervention to improve adherence to medication for hypertension, dyslipidemia, and chronic venous circulation disorders in Greece. Patient Prefer Adherence. 2023;17:3341-52. doi:10.2147/PPA.S420811.
5. Falch C, Alves G. Pharmacists’ role in older adults’ medication regimen complexity: a systematic review. Int J Environ Res Public Health. 2021;18(16):8824. doi:10.3390/ijerph18168824.
6. Farhana L, Rahayu FP, Sholihah S, Sweileh W, Abdulah R, Alfian SD. Effectiveness of pharmacist-led intervention on medication adherence in chronic diseases: a systematic review of randomized controlled trials. Patient Prefer Adherence. 2025;19:2161-78. doi:10.2147/PPA.S530503.
7. Wrzosek N, Danowski R. Survey of pharmacists’ opinion and knowledge on adverse drug reactions reporting in Poland. Curr Issues Pharm Med Sci. 2025;38(3):166-73. doi:10.12923/cipms-2025-0027.
8. Ministry of Health of the Republic of Indonesia. Indonesian health survey [Internet]. Jakarta: Ministry of Health of the Republic of Indonesia; 2023. Available from: https://kemkes.go.id/app_asset/file_content_download/17169067256655eae5553985.98376730.pdf
9. Prabhu K, Salwe KJ, Saravanabavan N, Manimekalai K. Medication adherence using medication possession ratio and proportion of days covered among elderly diabetic patients visiting a tertiary care hospital in Puducherry. Biomed Pharmacol J. 2023;16(1):179-88. doi:10.13005/bpj/2599.
10. Puspitasari IM, Azizah LN, Sinuraya RK, Alfian SD, Abdulah R. Measuring medication adherence of hypertensive patients with monotherapy treatment in a community health center by utilizing medication possession ratio. Pharmacia. 2022;69(2):345-50. doi:10.3897/pharmacia.69.e82330.
11. Jung W, Lee K, Kim HH, Lim C. How to construct analysis of covariance in clinical trials: ANCOVA with one covariate in a completely randomized design structure. Korean J Anesthesiol. 2025;78(4):315-20. doi:10.4097/kja.24820.
12. Septiani V, Kartidjo P, Islamiyah AN, Aziz MSWA, Rukmawati I. Identification of drug-related problems in hypertension comorbid type 2 diabetes mellitus patients at primary health care center Batununggal District Bandung. Borneo J Pharm. 2021;4(3):219-25. doi:10.33084/bjop.v4i3.1971.
13. Qiu L, Wang W, Sa R, Liu F. Prevalence and risk factors of hypertension, diabetes, and dyslipidemia among adults in Northwest China. Int J Hypertens. 2021;2021:5528007. doi:10.1155/2021/5528007.
14. Rezaianzadeh A, Johari MG, Baeradeh N, Seif M, Hosseini SV. Sex differences in hypertension incidence and risk factors: a population-based cohort study in Southern Iran. BMC Public Health. 2024;24:3595. doi:10.1186/s12889-024-21082-8.
15. Defianna SR, Santosa A, Probandari A, Sari FT, Dewi T, Cook D, et al. Gender differences in prevalence and risk factors for hypertension among adult populations: a cross-sectional study in Indonesia. Int J Environ Res Public Health. 2021;18(12):6259. doi:10.3390/ijerph18126259.
16. Fandinata SS, Darmawan R, Ulfa NM, Putra DA. Changes in mean arterial and blood pressure in using nicardipine in hypertensive crisis patients at the Hajj General Hospital Surabaya from August to December 2021. Borneo J Pharm. 2023;6(1):79-86. doi:10.33084/bjop.v6i1.3493.
17. Goorani S, Zangene S, Imig JD. Hypertension: a continuing public healthcare issue. Int J Mol Sci. 2025;26(1):123. doi:10.3390/ijms26010123.
18. Nobakht N, Afshar Y, Vaseghi M, Li Z, Donangelo I, Lavretsky H, et al. Hypertension management in women with a multidisciplinary approach. Mayo Clin Proc. 2025;100(3):514-33. doi:10.1016/j.mayocp.2024.10.005.
19. Uko MAJ, Virginia DM. Drug interaction study of antihypertension in geriatric patients diagnosed hypertension at Puskesmas Mauponggo, Nusa Tenggara Timur. Majalah Farmaseutik. 2024;20(2):167-73. doi:10.22146/farmaseutik.v20i2.84773.
20. Kosami K, Kuwabara M, Okayama A, Ae R. Body mass index and weight change as predictors of hypertension development: a sex-specific analysis. Nutrients. 2025;17(1):119. doi:10.3390/nu17010119.
21. Song L, Li J, Yu S, Cai Y, He H, Lun J, et al. Body mass index is associated with blood pressure and vital capacity in medical students. Lipids Health Dis. 2023;22:189. doi:10.1186/s12944-023-01920-1.
22. Yang R, Tang J, Kuang M, Liu H. Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study. Ann Med. 2023;55(1):276-84. doi:10.1080/07853890.2022.2162113.
23. Suneja K, Singh S, Sindhu S, Singh S, Kumar N, Kumar A, et al. Prescribing trends of antihypertensive medications: an observational study in a tertiary care hospital in India. Cureus. 2026;18(1). doi:10.7759/cureus.101424.
24. Shankpal PD, Lohi SM, Karande S, Bonde VN. A study of the prescription patterns of antihypertensive drugs in patients attending the outpatient department of medicine at a tertiary care hospital. Cureus. 2025;17(7). doi:10.7759/cureus.88270.
25. Damania H, Kolhe D, Kadam S, Rajput J, Devarshi SP, Shaikh A, et al. Evaluation of prescription pattern of antihypertensives and its compliance with Joint National Committee 8 guidelines in hospital setting. J Assoc Physicians India. 2024;72(12). doi:10.59556/japi.72.0760.
26. Dawane J, Suryawanshi S, Jain H, Dhande P, Shukla S. Comparative study of valsartan and leucovorin alone or in combination for renal protection in methotrexate-induced acute kidney injury in rats. Curr Issues Pharm Med Sci. 2026;39(1):53-8. doi:10.12923/cipms-2026-0009.
27. Alexander T, Hiremath JS, Sawhney JPS, Chandra S, Jain P, Chandra P, et al. Identifying drug prescription in newly diagnosed hypertension patients in India. J Clin Hypertens (Greenwich). 2025;27. doi:10.1111/jch.14963.
28. Paudel N, Shrestha S, Marasine NR, Khanal P, Aryal S, Erku D, et al. Impact of hospital pharmacist-delivered individualised pharmaceutical service intervention on clinical and patient-reported outcomes in patients with hypertension: a randomised controlled trial. Eur J Hosp Pharm. 2023;30(6):316-21. doi:10.1136/ejhpharm-2020-002512.
29. Huynh BH, Vo HT, Pham ATK, Tragulpiankit P, Huynh NH, Nguyen NL, et al. Effect of pharmacist-led interventions on hypertension-related knowledge, medication adherence, and blood pressure control: a multi-center, randomized, controlled trial in Vietnam. J Am Coll Clin Pharm. 2024;7(6):544-53. doi:10.1002/jac5.1955.
30. Li Y, Liu G, Liu C, Wang X, Chu Y, Li X, et al. Effects of pharmacist intervention on community control of hypertension: a randomized controlled trial in Zunyi, China. Glob Health Sci Pract. 2021;9(4):890-904. doi:10.9745/GHSP-D-20-00505.
31. Soubra L, Elba G. Pharmacist role in hypertension management in the community setting: questionnaire development, validation, and application. Patient Prefer Adherence. 2023;17:351-67. doi:10.2147/PPA.S394855.
32. Gastens V, Tancredi S, Kiszio B, Del Giovane C, Tsuyuki RT, Paradis G, et al. Pharmacists delivering hypertension care services: a systematic review and meta-analysis of randomized controlled trials. Front Cardiovasc Med. 2025;12:1477729. doi:10.3389/fcvm.2025.1477729.
33. Arwinda P, Virginia DM, Hendra P. The effect of adherence to antihypertensive therapy and cardiovascular risk among hypertensive patients in Purworejo Regency. J Pharm Sci Community. 2025;21(2):190-9. doi:10.24071/jpsc.007334.
34. Malkon S, Wettermark B, Kahan T, Bastholm-Rahmner P, Hasselström J, Qvarnström M. A qualitative study on patients’ views on hypertension and antihypertensive medications. Patient Prefer Adherence. 2023;17:3331-9. doi:10.2147/PPA.S429638.
35. Wewege MA, Hansford HJ, Shah B, Gilanyi YL, Douglas SRG, Parmenter BJ, et al. Baseline imbalance and heterogeneity are present in meta-analyses of randomized clinical trials examining the effects of exercise and medicines for blood pressure management. Hypertens Res. 2022;45:1643-52. doi:10.1038/s41440-022-00984-3.
36. Suryaningsih B. The effectiveness of structured pharmaceutical education on medication adherence and blood pressure control among hypertensive patients at the Prafi Health Center. J Community Engagem Health. 2026;9(1):73-9. doi:10.30994/jceh.v9i1.789.
37. de Souza Cazarim M, Cruz-Cazarim ELC, Boyd K, Wu O, Nunes AA. Effect of medication therapy management by pharmaceutical care on blood pressure and cardiovascular risk in hypertension: a systematic review, meta-analysis, and meta-regression. Pharmaceuticals (Basel). 2023;16(6):845. doi:10.3390/ph16060845.
38. Hamrahian SM, Maarouf OH, Fülöp T. A critical review of medication adherence in hypertension: barriers and facilitators clinicians should consider. Patient Prefer Adherence. 2022;16:2749-57. doi:10.2147/PPA.S368784.
39. Mills KT, O’Connell SS, Pan M, Obst KM, He H, He J. Role of health care professionals in the success of blood pressure control interventions in patients with hypertension: a meta-analysis. Circ Cardiovasc Qual Outcomes. 2024;17(8). doi:10.1161/CIRCOUTCOMES.123.010396.
40. Rahayu SA, Widianto S, Defi IR, Abdulah R. Role of pharmacists in the interprofessional care team for patients with chronic diseases. J Multidiscip Healthc. 2021;14:1701-10. doi:10.2147/JMDH.S309938.
41. Husaini DC, Barillas S, Dyck L, Camal R, Nwokocha C, Orisakwe OE. Community-based interventions for hypertension control in Latin America and the Caribbean: a systematic review of randomized controlled trials. J Prim Care Community Health. 2026;17:21501319261424355. doi:10.1177/21501319261424355.
42. Mozu IE, Marfo AFA, Opare-Addo M, Buabeng KO, Owusu-Daaku FT. Exploring the role of pharmacists in improving blood pressure control among hypertensive patients at the workplace. Sci Afr. 2021;14. doi:10.1016/j.sciaf.2021.e00983.
43. Sorato MM, Davari M, Kebriaeezadeh A, Sarrafzadegan N, Shibru T, Fatemi B. Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review. BMC Cardiovasc Disord. 2021;21(1):123. doi:10.1186/s12872-021-01934-6.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 A.A. Sagung Istri Iryaningrat , Zita Dhirani Pramono, Dita Maria Virginia (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
